Adnexus Therapeutics - Ownership and Business Overview

Life ScienceCompany

Adnexus Therapeutics Ownership

Who owns Adnexus Therapeutics?

Adnexus Therapeutics is owned by Bristol-Myers Squibb. It was acquired on September 27, 2007.

Adnexus Therapeutics Business Overview

Where is Adnexus Therapeutics headquartered?

Adnexus Therapeutics is headquartered in Waltham, Massachusetts.

How many employees does Adnexus Therapeutics have?

Adnexus Therapeutics has 58 employees.

What sector is Adnexus Therapeutics in?

Adnexus Therapeutics is a life science company.

When was Adnexus Therapeutics founded?

Adnexus Therapeutics was founded in 2002.

Life Science M&A Summary in 2007

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2007. The largest life science acquisition in 2007 was Organon BioSciences N.V. - which was acquired by Schering-Plough for $12.4B.

Join Mergr to view all 131 acquisitions of life science companies in 2007, including 29 acquisitions by private equity firms, and 102 by strategics.

Adnexus Therapeutics

Adnexus Therapeutics, Inc.

100 Beaver Street,
Waltham, Massachusetts 02453
United States,
(781) 891-3745
www.adnexustx.com

Adnexus Therapeutics is a developer of a new therapeutic class of biologics called Adnectins. Adnexus Therapeutics was founded in 2002 and is based in Waltham, Massachusetts.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.